Back
Novo Nordisk AS Vs. GitLab Industry Stock Comparison
Sell
30
NONOF
Novo Nordisk AS
Last Price:
$81.99
Seasonality Move:
8.27%
Buy
59
GTLB
GitLab
Last Price:
$71.55
Seasonality Move:
-31.91%
Sell
30
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $78.18. The Score for NONOF is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $78.18Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing selling pressure, which indicates risk of future bearish movement.
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.16 | Sell |
Relative Strength Index (14 RSI): | 35.41 | Sell |
Chaikin Money Flow: | -562504 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (80.8 - 85.88) | Sell |
Bollinger Bands (100): | (87.27 - 116.13) | Sell |
GTLB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.94 | Buy |
Relative Strength Index (14 RSI): | 50.95 | Buy |
Chaikin Money Flow: | -1465894 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (62.89 - 71.63) | Buy |
Bollinger Bands (100): | (54.07 - 66.43) | Buy |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 83.33 | Sell |
20-day SMA: | 83.36 | Sell |
50-day SMA: | 90.56 | Sell |
200-day SMA: | 118.35 | Sell |
8-day EMA: | 81.95 | Sell |
20-day EMA: | 83.79 | Sell |
50-day EMA: | 89.98 | Sell |
200-day EMA: | 107.76 | Sell |
GTLB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 70.39 | Sell |
20-day SMA: | 68.79 | Sell |
50-day SMA: | 63.91 | Buy |
200-day SMA: | 55.08 | Buy |
8-day EMA: | 69.7 | Sell |
20-day EMA: | 68.38 | Sell |
50-day EMA: | 64.91 | Buy |
200-day EMA: | 58.15 | Buy |
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
GitLab Earnings Growth & GTLB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.02 per share, an increase this year of $0.50 per share, and an increase next year of $0.18 per share.
Novo Nordisk AS Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
GitLab Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |